{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/23/3316415/0/en/Agomab-Announces-Design-of-NOV-ERA-Phase-2b-Study-with-Ontunisertib-in-Fibrostenosing-Crohn-s-Disease.html", "message": "News view counter 812547 successfully enlarged"}